ISS National Lab

The ISS National Lab is a nonprofit organization that manages the International Space Station (ISS) as a unique laboratory for Earth. It provides access to microgravity and space environments for researchers from various fields, such as biology, technology, medicine, and education. The site publishes news articles about its projects and activities on the ISS, such as sponsoring cancer research experiments that test chemotherapy effectiveness in microgravity.

99%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Exploring Cancer Treatment Options in Microgravity: A Look at the ISS National Laboratory's Research Efforts

    Exploring Cancer Treatment Options in Microgravity: A Look at the ISS National Laboratory's Research Efforts

    Broke On: Monday, 25 March 2024 Researchers are using microgravity conditions available through the International Space Station (ISS) National Laboratory to explore how to mitigate cancer effects and improve treatment options for patients on Earth. Chemotherapy drugs work by killing cancer cells within the body, but nearly 80% of initial treatments do not work, meaning individuals have to endure multiple rounds.